Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications

被引:12
作者
Bashir, Mohammad [1 ]
Elhadd, Tarik [1 ,2 ]
Dabbous, Zeinab [1 ]
Gul, Wajiha [1 ]
Salameh, Obada [1 ]
Siddiqui, Mashhood [1 ]
Al-Muhannadi, Hamad [3 ]
Petropoulos, Ioannis [3 ]
Khan, Adnan [3 ]
Ponirakis, Georgios [3 ]
Malik, Rayaz A. [3 ,4 ]
机构
[1] Hamad Gen Hosp, Hamad Med Corp, Natl Diabet & Endocrine Ctr, Doha, Qatar
[2] Al Wakra Hosp, Hamad Med Corp, Natl Diabet & Endocrine Ctr, Doha, Qatar
[3] Weill Cornell Med Qatar, Qatar Fdn, POB 24144, Doha, Qatar
[4] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England
关键词
Diabetic neuropathy; Retinopathy; Microalbuminuria; Type; 2; diabetes; Glycemia; Blood pressure; Lipids; MULTIFACTORIAL INTERVENTION; NEUROPATHIC PAIN; GLUCOSE CONTROL; RISK-FACTORS; MELLITUS; PROGRESSION; THERAPIES; MORTALITY; OUTCOMES; DN4;
D O I
10.1016/j.dsx.2021.102241
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetic microvascular complications are a major cause of morbidity and are related to glycaemic control and cardiovascular risk factors. Aims: We sought to determine the association of microvascular complications in relation to control of glycemia, blood pressure and lipids in T2DM patients attending secondary care in Qatar. Methods: This is a cross-sectional study undertaken in patients with T2DM attending Qatar's National Diabetes Centres. Patients underwent assessment of glycemia, blood pressure and lipids and prevalence of diabetic peripheral neuropathy (DPN), retinopathy and microalbuminuria. Results: We included 1114 subjects aged 52.1 +/- 11.3 years with a duration of diabetes 10.0 +/- 7.6 years and had a prevalence of 25.8% for DPN, 34.3% for painful DPN, 36.8% for microalbuminuria and 25.1% for retinopathy. Patients who achieved an HbA1c <= 7.0% compared to >7% had a significantly lower prevalence of DPN (P < 0.01), painful DPN (P < 0.01), retinopathy (P < 0.01) and microalbuminuria (P < 0.007). Patients who achieved a systolic BP <= 140 mmHg compared to >140 mmHg had a significantly lower prevalence of DPN (P < 0.001), painful DPN (P < 0.001), retinopathy (P < 0.001) and microalbuminuria (P < 0.001). Patients who achieved an LDL <= 2.6 mmol/l compared to >2.6 mmol/l had a significantly higher prevalence of DPN (P < 0.03), but no difference in other outcomes. There was no difference in microvascular complications between those who achieved a HDL-C >= 1.02 mmol/l, and among those who achieved triglycerides <= 1.7 mmol/l. Conclusions: Optimal control of glycemia and blood pressure, but not lipids is associated with a lower prevalence of diabetic microvascular complications. (C) 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页数:6
相关论文
共 47 条
  • [1] Al-Thani Al Anoud, 2012, Qatar stepwise report 2012 chronic disease risk factor surveillance, P1
  • [2] Subclinical neuropathy among diabetes control and complications trial participants without diagnosable neuropathy at trial completion
    Albers, James W.
    Herman, William H.
    Pop-Busui, Rodica
    Martin, Catherine L.
    Cleary, Patricia
    Waberski, Barbara
    [J]. DIABETES CARE, 2007, 30 (10) : 2613 - 2618
  • [3] Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2020
    不详
    [J]. DIABETES CARE, 2020, 43 : S193 - S202
  • [4] [Anonymous], 2019, IDF Diabetes Atlas, V9th
  • [5] Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease
    Arya, Shipra
    Khakharia, Anjali
    Binney, Zachary O.
    DeMartino, Randall R.
    Brewster, Luke P.
    Goodney, Philip P.
    Wilson, Peter W. F.
    [J]. CIRCULATION, 2018, 137 (14) : 1435 - 1446
  • [6] Forecasting the burden of type 2 diabetes mellitus in Qatar to 2050: A novel modeling approach
    Awad, Susanne F.
    O'Flaherty, Martin
    Critchley, Julia
    Abu-Raddad, Laith J.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 100 - 108
  • [7] The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM)
    Azad, N
    Emanuele, NV
    Abraira, C
    Henderson, WG
    Colwell, J
    Levin, SR
    Nuttall, FQ
    Comstock, JP
    Sawin, CT
    Silbert, C
    Rubino, FA
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1999, 13 (5-6) : 307 - 313
  • [8] Behl T, LIFE SCI, V176
  • [9] Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.
    Chew, Emily Y.
    Ambrosius, Walter T.
    Davis, Matthew D.
    Danis, Ronald P.
    Gangaputra, Sapna
    Greven, Craig M.
    Hubbard, Larry
    Esser, Barbara A.
    Lovato, James F.
    Perdue, Letitia H.
    Goff, David C., Jr.
    Cushman, William C.
    Ginsberg, Henry N.
    Elam, Marshall B.
    Genuth, Saul
    Gerstein, Hertzel C.
    Schubart, Ulrich
    Fine, Lawrence J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) : 233 - 244
  • [10] Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry
    Fan, Wenjun
    Song, Yang
    Inzucchi, Silvio E.
    Sperling, Laurence
    Cannon, Christopher P.
    Arnold, Suzanne V.
    Kosiborod, Mikhail
    Wong, Nathan D.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (05) : 1121 - 1127